| abstract |
The present application relates to prodrug derivatives of 2-amino-6-({[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl}thio)-4-[4-(2-hydroxyethoxy)phenyl]pyridin-3,5-dicarbonitrile, process for the preparation thereof, the use thereof for the treatment and/or prophylaxis of diseases, and the use thereof for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of cardiovascular disorders. |